VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
46,870MODERNA
532GLAXOSMITHKLINE BIOLOGICALS
353PFIZER\BIONTECH
231MERCK & CO. INC.
221UNKNOWN MANUFACTURER
62SEQIRUS, INC.
25DYNAVAX TECHNOLOGIES CORPORATION
13EMERGENT BIOSOLUTIONS
12SANOFI PASTEUR
9NOVARTIS VACCINES AND DIAGNOSTICS
5PFIZER\WYETH
5PAXVAX
2TEVA PHARMACEUTICALS
2PROTEIN SCIENCES CORPORATION
1BERNA BIOTECH, LTD.
1INTERCELL AG
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL1,906
1,575
289
IMM209286
252
236
229
s029456178
171
UT7065MA166
155
149
145
S034636133
107
U62828AA103
100
98
P10025327596
U6737AA85
UJ446AA79
78
78
59
57
4BH3254
4F47253
52
27656352
50
PP9L548
49TM346
42
40
38
MENVEO38
4F47237
R1B252M36
34
C5763AA30
93362229
25
300057A24
UNK24
22
CW311621
18
17
15
UH894AB15
3Y7NL12
R1B743M12
EJ168611
el128410
10
10
10
9
ARBA141A9
UNK9
8
UNK8
8
1F4EB8
Unknown7
7
No batch number6
5
5
UJ090AA5
5
5
4
4
4
UNK4
JEV18K95E4
UNK3
A115A3
Z127A3
3
3333324181073
2
2
2
TAR352
1
1
1
1
1
A739081
1
1
1
1
1
037K20A68,542
EL128447,700
133

Incidents per State

State Total
15,185
CA14,096
NY7,507
TX7,196
FL6,939
IN5,527
PA4,560
IL4,179
OH4,054
AZ3,856
MI3,771
NJ3,411
MA3,278
VA3,208
NC3,114
WA3,034
GA2,864
MD2,652
MN2,534
CO2,532
WI2,457
MO2,029
OR1,943
TN1,715
CT1,693
KY1,603
OK1,226
AL1,201
KS1,162
IA1,157
SC1,106
NM1,065
UT973
AR951
LA945
NE829
NV797
ME795
MT789
NH756
ID674
AK661
WV661
PR650
MS585
HI536
RI510
VT441
SD361
ND356
DE350
DC239
WY209
GU32
AS16
VI13
MP9
MH3
FM2
QM1
XB1

ID: 0945962
Sex: F
Age:
State:

Vax Date: 01/04/2021
Onset Date: 01/05/2021
Rec V Date: 01/15/2021
Hospital:

Lab Data: Test Date: 20210105; Test Name: temperature; Result Unstructured Data: Test Result:99.3 Fahrenheit; Test Date: 20210107; Test Name: temperature; Result Unstructured Data: Test Result:98.3 Fahrenheit; Test Date: 20210107; Test Name: temperature; Result Unstructured Data: Test Result:97.6 Fahrenheit; Test Date: 20210108; Test Name: temperature; Result Unstructured Data: Test Result:99.2 Fahrenheit; Test Date: 20210108; Test Name: temperature; Result Unstructured Data: Test Result:98.3 Fahrenheit; Test Date: 20210109; Test Name: temperature; Result Unstructured Data: Test Result:99.7 Fahrenheit

Allergies:

Symptoms: temperature of 99.3F, 98.3F, 99.2F, 99.7F; This is a spontaneous report from a contactable consumer (patient herself). A female patient of an unspecified age received his first dose of bnt162b2 (BNT162B2 also reported as PFIZER-BIONTECH COVID-19 VACCINE, lot/batch number and expiry date were not reported), via an unspecified route of administration on 04Jan2021 at single dose for Covid-19 immunisation. The patient's medical history and concomitant medications were not reported. On Tuesday (05Jan2021), she woke up with a temperature of 99.3F. On Thursday (07Jan2021) evening, she had a temperature of 98.3F, then she took Tylenol and her temperature was back to normal which she noted that her temperature is 97.6F. Yesterday (08Jan2021) at 6pm, she had a temperature of 99.2F and she took Tylenol at 10PM and her temperature was 98.3F. Her temperature today (09Jan2021) was 99.7F and she didn't take Tylenol. The outcome of event was unknown. Information about lot/batch has been requested.

Other Meds:

Current Illness:

ID: 0945963
Sex: F
Age:
State: AR

Vax Date: 12/30/2020
Onset Date: 12/31/2020
Rec V Date: 01/15/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Chills; Night Sweats; Body Aches; Dizziness; Headache; fatigue; weakness; joint pain; nausea; This is a spontaneous report from a contactable health care professional, the patient. A 37-years-old non-pregnant female patient (health care professional) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot Number: EK9231), in the right arm on 30Dec2020 13:00 as a single dose, for COVID-19 vaccination. The vaccine was administered at a Pharmacy or Drug Store. Medical History include drug allergy to sulfa. Concomitant medication included Microgestin, Biotin and Prenatal Vitamin. No other vaccines were given within 4 weeks. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination the patient had not been tested for COVID-19. On 31Dec2020 , the patient experienced Chills, Night Sweats, Body Aches, Dizziness, Headache, fatigue, weakness, joint pain, nausea. No treatment was received given for the event. The clinical outcome of Chills, Night Sweats, Body Aches, Dizziness, Headache, fatigue, weakness, joint pain, nausea was recovering.

Other Meds: MICROGESTIN; ; PRENATAL VITAMINS [ASCORBIC ACID;BETACAROTENE;CALCIUM SULFATE;COLECALCIFEROL;CYANOCOBALAMIN;FERROUS

Current Illness:

ID: 0945964
Sex: M
Age:
State: MI

Vax Date: 01/08/2021
Onset Date: 01/08/2021
Rec V Date: 01/15/2021
Hospital:

Lab Data:

Allergies:

Symptoms: chills; muscle ache/muscle pain about 10 hours after injection; headache; Dose Number: 2, Date of start of drug: 08Jan2021; This is a spontaneous report received from a contactable physician (who is also the patient). A 59-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: ek9231), via an unspecified route of administration in left arm, on 08Jan2021 12:00, at single dose, for COVID-19 immunization, in the hospital. Medical history included polymyalgia rheumatica. The patient has no known allergies. Concomitant medication included methotrexate and folic acid. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: el0140), via an unspecified route of administration in left arm, on 22Dec2020 at 11:00, for COVID-19 immunization. The patient experienced chills, muscle ache, headache, and muscle pain about 10 hours after injection on 08Jan2021 at 22:00. The patient did not receive treatment for the events. Prior to vaccination, the patient was not diagnosed with COVID-19. Since vaccination, the patient has not been tested for COVID-19. The outcome of the events chills, muscle ache/muscle pain about 10 hours after injection and headache was recovering.

Other Meds: ;

Current Illness:

ID: 0945965
Sex: F
Age:
State: IL

Vax Date: 12/18/2020
Onset Date:
Rec V Date: 01/15/2021
Hospital:

Lab Data:

Allergies:

Symptoms: headache; arm pain; This is a spontaneous report from a contactable other healthcare professional (patient). A 28-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date not reported), via an unspecified route of administration on 18Dec2020 09:30 at a single dose on left arm for COVID-19 immunization. Medical history included Postural orthostatic tachycardia syndrome. Concomitant medication included spironolactone and metoprolol. The patient experienced headache and arm pain on an unspecified date after first dose (reported as "First dose: headache, arm pain"). No treatment received for adverse events. The outcome of the events was recovering. The events were assessed as non-serious. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. Information on the lot/ batch number has been requested.

Other Meds: ;

Current Illness:

ID: 0945966
Sex: F
Age:
State: CA

Vax Date: 01/08/2021
Onset Date: 01/09/2021
Rec V Date: 01/15/2021
Hospital:

Lab Data: Test Date: 20210109; Test Name: temperature; Result Unstructured Data: Test Result:99-100.6

Allergies:

Symptoms: Inject site pain; muscle/joint pain; muscle/joint pain; fever with temperature of 99-100.6 [units unspecified]; under arm lymph node pain; headache; This is a spontaneous report from a contactable healthcare professional. A 41-year-old non-pregnant female patient received her second dose of bnt162b2 (BNT162B2 reported as COVID-19 vaccine; lot number: EL1284; expiration date: unknown), intramuscular left arm on 08Jan2021 08:45 AM at a single dose for covid-19 vaccination. Medical history included asthma, allergies, high blood pressure and gastric sleeve. Concomitant medication included albuterol [salbutamol] (ALBUTEROL [SALBUTAMOL]), beclometasone dipropionate (QVAR), mometasone furoate (FLONASE), aminobenzoic acid, calcium pantothenate, cyanocobalamin, nicotinamide, pyridoxine hydrochloride, riboflavin, thiamine hydrochloride (B-COMPLEX), cyanocobalamin (B-12), colecalciferol (D) and macrogol 3350 (MIRALAX). The patient previously took vancomycin but had allergies. The patient received the first dose of bnt162b2 (BNT162B2 reported as COVID-19 vaccine; lot number: EK5730; expiration date: unknown) intramuscular left arm on 18Dec2020 07:45 AM at a single dose for covid-19 vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. The patient received the most recent COVID-19 vaccine in a hospital. The patient experienced inject site pain, muscle/joint pain, fever with temperature of 99-100.6 [units unspecified], under arm lymph node pain and headache on 09Jan2021 23:30. The events were considered as non-serious. The treatment the patient received for the adverse event were acetaminophen (TYLENOL), fluids, ice packs and magnesium. The patient has not been tested for COVID-19 since the vaccination. The patient underwent lab tests and procedures which included temperature was 99-100.6 [units unspecified] on 09Jan2021. The outcome of the events was recovering.

Other Meds: ALBUTEROL [SALBUTAMOL]; QVAR; FLONASE [MOMETASONE FUROATE]; B-COMPLEX [AMINOBENZOIC ACID;CALCIUM PANTOTHENATE;CYANOCOBALAMIN;NICOTINAMIDE;PYRIDOXINE HYDROCHLORI; B-12; D; MIRALAX

Current Illness:

ID: 0945967
Sex: F
Age:
State: IN

Vax Date: 12/21/2020
Onset Date: 12/22/2020
Rec V Date: 01/15/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Mild pain at injection site and runny nose/sneezing day after vaccine; Mild pain at injection site and runny nose/sneezing day after vaccine; Mild pain at injection site and runny nose/sneezing day after vaccine; This is a spontaneous report from a contactable pharmacist (patient herself). A 30-year-old female patient received her first dose of bnt162b2 (BNT162B2 also reported as COVID 19 brand Pfizer, lot Ej1685), via an unspecified route of administration in the left arm on 21Dec2020 12:00 at single dose for Covid-19 immunisation. Medical history included allergy to PCN (rash to PCN as a child). No other vaccine in four weeks prior to Covid-19 vaccine. No Covid-19 prior to vaccination. The patient's concomitant medications were not reported. The patient experienced mild pain at injection site and runny nose/sneezing day after vaccine (22Dec2020). No treatment was given to the patient. The outcome of events was recovered.

Other Meds:

Current Illness:

ID: 0945968
Sex: F
Age:
State: NJ

Vax Date: 01/05/2021
Onset Date: 01/05/2021
Rec V Date: 01/15/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Chills; Body ache; Fatigue; redness and hot about 1-3 inches below injection site; redness and hot about 1-3 inches below injection site; patient received the second dose in less than 21 days from the first dose; This is a spontaneous report from a contactable nurse, the patient. A 53-year-old non-pregnant female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EJ0142), intramuscular in the left arm on 05Jan2021 at 08:00 AM (at the age of 53-year-old) as a single dose for COVID-19 immunization. Medical history was none. The patient did not have any allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. There were no concomitant medications. The patient previously received the first dose of BNT162B2 intramuscular on 19Dec2020 at 19:00 PM, lot number: EJ1685 at the age of 53-year-old for COVID-19 immunization in the left arm. The patient did not receive any other vaccines within four weeks prior to the second vaccination (except the first vaccination). On 05Jan2021 at 22:00 PM the patient experienced chills, body ache, fatigue, redness and hot about 1-3 inches below injection site. The patient took Motrin for chills, body ache, fatigue, redness and hot about 1-3 inches below injection site. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcomes of the chills, body ache, fatigue, redness and hot about 1-3 inches below injection site was not recovered.

Other Meds:

Current Illness:

ID: 0945969
Sex: F
Age:
State:

Vax Date: 01/06/2021
Onset Date: 01/08/2021
Rec V Date: 01/15/2021
Hospital:

Lab Data: Test Date: 20210108; Test Name: Blood pressure; Result Unstructured Data: Test Result:went up

Allergies:

Symptoms: Headache; Blood pressure went up; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age (reported as "Age 85: Unit Unknown") received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: not provided), via an unspecified route of administration on 06Jan2021 at single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient received first dose of COVID-19 vaccine on Wednesday 06Jan2021 and reported that on Friday 08Jan2021, she had a headache and blood pressure went up. Patient asked if these are side effects of the vaccine. Patient stated that someone saw on internet that high blood pressure can be from vaccine. Outcome of the events was unknown. Information about batch/lot number has been requested.

Other Meds:

Current Illness:

ID: 0945970
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 01/15/2021
Hospital:

Lab Data: Test Name: COVID; Test Result: Positive

Allergies:

Symptoms: Receives dose #1 of the covid vaccine and contracts covid prior to dose #2; Receives dose #1 of the covid vaccine and contracts covid prior to dose #2; This is a spontaneous report from a contactable physician via Pfizer sales representative. This physician reported similar events for two patients. This is 2nd of two reports. A patient of unspecified age and gender received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot/batch number and expiry date were not provided) solution for injection, via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. It was reported that patient received dose #1 of the COVID vaccine and contracts COVID prior to dose #2 on an unspecified date. The patient underwent lab test which included Covid-19 test in which he/she tested positive on an unknown date. Outcome of the events was unknown. Information about batch/lot number has been requested.; Sender's Comments: A causal association between BNT162B2 and the reported events cannot be excluded based on a compatible temporal relation between vaccination and onset of events. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and Investigators, as appropriate. ,Linked Report(s) : US-PFIZER INC-2021012928 Same reporter/drug/event, different patient

Other Meds:

Current Illness:

ID: 0945971
Sex: F
Age:
State:

Vax Date: 12/29/2020
Onset Date: 12/31/2020
Rec V Date: 01/15/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Itchy head, which progressed to other parts of the body in the following days; Bumps all over body; Some discomfort with breathing when taking a deep breath; This is a spontaneous report from a contactable consumer (relative). A female patient of an unspecified age (reported as "Pt age: 25", unit: unknown) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: not provided), via an unspecified route of administration on 29Dec2020 at single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. On 31Dec2020, patient experienced itchy head, which progressed to other parts of the body in the following days. The patient also experienced bumps all over body and some discomfort with breathing when taking a deep breath. Outcome of the events was not recovered (reported as "ongoing"). Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0945972
Sex: F
Age:
State: AZ

Vax Date: 12/30/2020
Onset Date: 12/31/2020
Rec V Date: 01/15/2021
Hospital:

Lab Data: Test Name: Body temperature; Result Unstructured Data: Test Result:103; Test Name: heart rate; Result Unstructured Data: Test Result:from 60s to 50s all over the place

Allergies:

Symptoms: My heart rate, I was like in AFib; very high fever of 103; dizzy, light headed; arms sore; exhausted like an extreme fatigue; palpitations; This is a spontaneous report from a contactable consumer (patient). A 38-year-old female patient received the bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot Number: EH9899), via an unspecified route of administration on 30Dec2020 at 38-years-old at a single dose for COVID-19 immunization. Medical history included blood clotting disorder from an unknown date and unknown if ongoing. The patient experienced the following events and outcomes: my heart rate, I was like in AFib (medically significant) on 31Dec2020 with outcome of recovering, very high fever of 103 (non-serious) on 31Dec2020 with outcome of unknown, dizzy, light headed (non-serious) on 31Dec2020 with outcome of unknown, arms sore (non-serious) on 31Dec2020 with outcome of unknown, exhausted like an extreme fatigue (non-serious) on 31Dec2020 with outcome of not recovered, palpitations (non-serious) on 31Dec2020 with outcome of not recovered. The clinical course was reported as follows: The patient stated, "the day after the shot I got a very high fever of 103. I was dizzy, lightheaded. My heart rate I was like in AFib, it was going from 60s to 50s all over the place. And this was the next day after the vaccination. That evening nothing my arms was just sore. But the next day all of these side effects just started in and even still today I just feel so exhausted like an extreme fatigue and I am still getting like palpitations." The patient stated, "So I went to urgent care and they check my vitals and stuff and when they wanted me to send me to the hospital. But I told them I will get a ride and I go by myself just because I didn't want, capable of an ambulance ride and I ended up just going home because I couldn't get a hold up anybody. So, I came home and took my blood thinner medication because I do have blood clotting disorder." In regard to the outcomes of the events, the patient stated, "I am not experiencing all of them still definitely my heart is much better. I am still getting palpitations but nothing near how it was that first day. I am experiencing extreme fatigue."

Other Meds:

Current Illness:

ID: 0945973
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 01/15/2021
Hospital:

Lab Data:

Allergies:

Symptoms: mild headache/splitting headache; soreness/muscle soreness in the posterior chain (shoulder, back, traps); lack of of energy; "like having too much to drink and achy" and is currently ramping up; "like having too much to drink and achy" and is currently ramping up; This is a spontaneous report from a contactable other healthcare professional (patient). An adult male patient of an unspecified age (Age: 28; Unit: Unknown) received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration from an unspecified date to an unspecified date as SINGLE DOSE for COVID-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. Historical vaccine includes first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) on 23Dec2020 for COVID-19 immunization and the patient experienced mild headache and soreness, muscle soreness in the posterior chain (shoulder, back, traps), splitting headache, lack of energy. Upon receiving second dose of the vaccine, the patient experienced same symptoms, mild headache and soreness, muscle soreness in the posterior chain (shoulder, back, traps), splitting headache, lack of energy, and additionally stated "like having too much to drink and achy" and is currently ramping up. The outcome of the events was unknown. Information about batch/lot number has been requested.

Other Meds:

Current Illness:

ID: 0945974
Sex: F
Age:
State: PA

Vax Date: 01/08/2021
Onset Date: 01/08/2021
Rec V Date: 01/15/2021
Hospital:

Lab Data: Test Date: 20210108; Test Name: fever; Result Unstructured Data: Test Result:100.2 Fahrenheit; Comments: low grade fever

Allergies:

Symptoms: Profusely sweat; Body aches; Chills; Get hives on my face and chest; Had a low grade fever. 100.2 F; Dose Number:1/ Date of start of drug: 21Dec2020/ Dose Number:2/ Date of start of drug: 08Jan2021; Dose Number:1/ Date of start of drug: 21Dec2020/ Dose Number:2/ Date of start of drug: 08Jan2021; This is a spontaneous report from a contactable nurse (patient). A 24-year-old female patient received her second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: ELO140), intramuscularly on left arm at 20:00 on 08Jan2021 at single dose for COVID-19 immunization. The patient medical history was not reported. Concomitant medication included cefalexin monohydrate (LEXIPRON), lisdexamfetamine mesilate (VYVANSE) and medication for birth control. The patient previously took Keflex and experienced drug allergy, first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: BLO140), intramuscularly on left arm at 06:00 AM on 21Dec2021 for COVID-19 immunization. An hour after the vaccination at 21:00 on 08Jan2021, the patient started to profusely sweat and get body aches and chills. The patient then started to get hives on her face and chest. The patient took Tylenol and Benadryl which helped the hives. The patient also had a low grade fever 100.2 F. The events were reported as non-serious. The outcome of events sweating, generalized aching, chills, hives and low grade fever was recovering. Prior to vaccination, the patient was not diagnosed with COVID-19; Since the vaccination, the patient had not been tested for COVID-19.

Other Meds: LEXIPRON; VYVANSE

Current Illness:

ID: 0945975
Sex: F
Age:
State:

Vax Date: 01/08/2021
Onset Date: 01/08/2021
Rec V Date: 01/15/2021
Hospital:

Lab Data: Test Date: 20210108; Test Name: Body temp; Result Unstructured Data: Test Result:99.7

Allergies:

Symptoms: Chills; fatigue; muscle aches so bad it made me cry; muscle aches so bad it made me cry; pain everywhere even clothes against my skin hurt/it was all I could do to physically get to bed, which hurt with every step; temp of 99.7; malaise; profound sleepiness; Arm pain at injection site; Arm pain at injection site; This is a spontaneous report from a contactable Physician reported for herself. A 33-years-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL1284), intramuscular at Left arm on 08Jan2021 09:00 at single dose for covid-19 immunization. The COVID-19 vaccine was administered at Hospital. Medical history included reported as none. There were no concomitant medications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient historic vaccine included the first dose of BNT162B2 on 18Dec2020 08:00 AM intramuscular at Left arm for covid-19 immunization. The patient experienced Chills, fatigue, muscle aches so bad it made her cry, pain everywhere even clothes against her skin hurt, temperature of 99.7, malaise, profound sleepiness, and it was all she could do to physically get to bed, which hurt with every step. Arm pain at injection site for 2 days now, could not sleep on that side, adverse event start date was provided as 08Jan2021 09:00 AM. No treatment received for the events. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient was not been tested for COVID-19. The outcome of the events was recovering. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 0945976
Sex: F
Age:
State:

Vax Date: 01/10/2021
Onset Date: 01/10/2021
Rec V Date: 01/15/2021
Hospital:

Lab Data: Test Date: 20210110; Test Name: Blood sugar; Result Unstructured Data: Test Result:Fine; Test Date: 20210110; Test Name: Blood pressure; Result Unstructured Data: Test Result:Fine

Allergies:

Symptoms: Dizziness; Tired; Weakness; Not feeling good; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EK9231), via an unspecified route of administration, on 10Jan2021 at 11:00, at a single dose, for COVID-19 immunization. The patient's medical history included vertigo-like dizziness (gets dizzy sometimes, every now and then). The patient's concomitant medication included dimenhydrinate (DRAMAMINE) for vertigo-like dizziness. The patient had the COVID-19 shot this morning at 11 o'clock (10Jan2021), it's been 8 hours now. The patient was asking if it was safe to take anything or could she take dimenhydrinate. It's been 8 hours since the patient had the vaccine and she only wanted to know if she can take dimenhydrinate because she was having dizziness around 7:30 PM. The patient was tired and did not want to hold, so warm call transfer was not attempted. The patient was about to call her pharmacist as soon as she was referred back to her healthcare professional and disconnected before she was offered the survey. Further that day, the patient reported that she was fine - meaning she had no reaction except felt dizzy around 7:30 or so (around 8 hours after administration). The patient looked at one of the complications and it could be dizziness and weakness, but she just felt a little dizzy and she gets like that sometime. That day (10Jan2021), the patient checked her blood pressure and blood sugar and they were both fine. The patient was just wondering if she could take the half of dimenhydrinate (reason of call). On paraphrasing the concern, the patient reported that she gets dizzy (vertigo-like dizziness) sometimes and she never takes a whole dimenhydrinate; she takes half of one and for this instance, the patient thought she would take half but she wanted to talk to Pfizer medical information first. In response to further questions, the patient stated that 8-10 minutes, she was not feeling good - patient can't do that (answering questions) and just needed some help. Limited information was available over the call as the patient was not willing to proceed with the questions. The events were considered non-serious. The outcome of the events was unknown.

Other Meds: DRAMAMINE

Current Illness:

ID: 0945977
Sex: F
Age:
State: UT

Vax Date: 12/21/2020
Onset Date: 12/01/2020
Rec V Date: 01/15/2021
Hospital:

Lab Data:

Allergies:

Symptoms: There was only mild discomfort with the first dose.; This is a spontaneous report from a contactable healthcare professional (patient herself). A 21-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL0140, expiry date not reported), via an unspecified route of administration in the right arm on 21Dec2020 11:30 at single dose for COVID-19 immunisation. Medical history was none. The patient was not pregnant at the time of vaccination. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, the patient has not been tested for COVID-19. The patient had no allergies to medications, food, or other products. Concomitant medications included aminobenzoic acid, biotin, choline bitartrate, cyanocobalamin, folic acid, inositol, iodine, iron, nicotinamide, pantothenic acid, pyridoxine hydrochloride, retinol acetate, riboflavin, thiamine hydrochloride, zinc (HAIRVITE), and ethinylestradiol, ferrous fumarate, norethisterone acetate (LO LOESTRIN FE). The patient experienced that there was only mild discomfort with the first dose on Dec2020. No therapeutic measure was taken as a result of the event. Clinical outcome of the event was unknown.

Other Meds: HAIRVITE; LO LOESTRIN FE

Current Illness:

ID: 0945978
Sex: F
Age:
State: NY

Vax Date: 12/18/2020
Onset Date:
Rec V Date: 01/15/2021
Hospital:

Lab Data: Test Date: 20201227; Test Name: Nasal Swab; Test Result: Negative

Allergies:

Symptoms: 1st - minimal pain right deltoid area at vaccination site; This is a spontaneous report from a contactable consumer (patient herself). A 35-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: Flo140, expiry date: 31Mar2021), via an unspecified route of administration in the right arm on 18Dec2020 12:00 at single dose for COVID-19 immunisation. Medical history included hypothyroidism. Concomitant medications included levothyroxine, vitamin c (ascorbic acid) (VITAMIN C), and colecalciferol (VITAMIN D). The patient was not pregnant at the time of vaccination. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, the patient has not been tested for COVID-19. The patient had no allergies to medications, food, or other products. The patient experienced 1st - minimal pain right deltoid area at vaccination site on an unspecified date. The patient underwent lab tests and procedures which included sars-cov-2 test: negative on 27Dec2020. Clinical outcome of the event was unknown.

Other Meds: ; VITAMIN C; VITAMIN D

Current Illness:

ID: 0945979
Sex: F
Age:
State: TX

Vax Date: 12/23/2020
Onset Date: 01/01/2021
Rec V Date: 01/15/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Itchiness, hives, wilts, abdominal pain; Itchiness, hives, wilts, abdominal pain; Itchiness, hives, wilts, abdominal pain; Itchiness, hives, wilts, abdominal pain; This is a spontaneous report from a contactable nurse (patient). A 30-year-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number unknown unable to locate or read the details) via an unspecified route of administration at Left arm on 23Dec2020 14:15 at single dose covid-19 immunization. Facility type vaccine was Hospital. No known allergies and no other medical history. Concomitant medication included ascorbic acid, calcium pantothenate, cyanocobalamin, ergocalciferol, nicotinamide, pyridoxine hydrochloride, retinol palmitate, riboflavin, thiamine mononitrate (PRENATAL VITAMINS), colecalciferol (VITAMIN D). No other vaccine in four weeks. The patient experienced itchiness, hives, wilts, abdominal pain on 01Jan2021 23:45. The events resulted in Doctor or other healthcare professional office/clinic visit. No covid prior vaccination and covid was not tested post vaccination. Treatment Benadryl was received for the events. The outcome of the events was recovered in Jan2021. Information about lot/batch number request.

Other Meds: PRENATAL VITAMINS [ASCORBIC ACID;CALCIUM PANTOTHENATE;CYANOCOBALAMIN;ERGOCALCIFEROL;NICOTINAMIDE;PYR; VITAMIN D [COLECALCIFEROL]

Current Illness:

ID: 0945980
Sex: F
Age:
State: UT

Vax Date: 01/07/2021
Onset Date: 01/07/2021
Rec V Date: 01/15/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Headache; body aches; joint pain; chills; fever; general malaise; dental pain; soreness at injection site; pain; Loose stools; Stomach upset; Dose Number:1/ Date of start of drug: 21Dec2020/ Dose Number:2/ Date of start of drug: 07Jan2021; Dose Number:1/ Date of start of drug: 21Dec2020/ Dose Number:2/ Date of start of drug: 07Jan2021; This is a spontaneous report from a contactable Other healthcare professional (patient). A 21-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number=EL0140), via an unspecified route of administration on left arm at 09:45 AM on 07Jan2021 at single dose for COVID-19 immunization. Medical history reported as none. Concomitant medication included ethinylestradiol, ferrous fumarate, norethisterone acetate (LO LOESTRIN FE) and Women's Daily Multivitamin, Hair Vits. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number=EL0140), on right arm at 11:30 AM on 21Dec2020 for COVID-19 immunization and experienced only mild discomfort. The patient experienced headache, body aches, joint pain, chills, fever, general malaise, dental pain, pain and soreness at injection site, loose stools, and stomach upset at 21:30 on 07Jan2021. The events were reported as non-serious. The patient did not receive any treatment for events. The outcome of events was not recovered. Prior to vaccination, the patient was not diagnosed with COVID-19; Since the vaccination, the had not patient been tested for COVID-19.

Other Meds: LO LOESTRIN FE

Current Illness:

ID: 0945981
Sex: F
Age:
State: NY

Vax Date: 01/06/2021
Onset Date: 01/07/2021
Rec V Date: 01/15/2021
Hospital:

Lab Data: Test Date: 20210105; Test Name: COVID test/Nasal swab; Test Result: Negative ; Comments: Nasal swab

Allergies:

Symptoms: Extreme Headache; chills; sore throat; water eyes; runny nose; tiredness; entire body aches; This is a spontaneous report from a contactable Nurse reporting for herself. A 42-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), intramuscular at left arm on 06Jan2021 14:45 at single dose for covid-19 immunization. The COVID-19 vaccine was administered at Nursing Home/Senior Living Facility. Medical history included prior to vaccination, the patient was diagnosed with COVID-19. The patient's concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced extreme Headache, chills, sore throat, water eyes, runny nose, tiredness entire body aches on 07Jan2021. No treatment was received for the events. Since the vaccination, the patient has been tested for COVID-19, the patient underwent lab tests and procedures which included Covid-19 test/Nasal Swab: negative on 05Jan2021. The outcome of the events was unknown. Information about lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0945982
Sex: F
Age:
State: HI

Vax Date: 01/07/2021
Onset Date: 01/07/2021
Rec V Date: 01/15/2021
Hospital:

Lab Data:

Allergies:

Symptoms: arm soreness (minor) day after; Headache (minor) day of; This is a spontaneous report from a contactable nurse (patient). A 27-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EJ1618; expiry date: unknown) via an unspecified route of administration (left arm), on 07Jan2021 at 12:15, at a single dose, for COVID-19 immunization. The patient's medical history was not reported. The patient has no known allergies (NKA). Concomitant medications included ascorbic acid, betacarotene, calcium sulfate, colecalciferol, cyanocobalamin, ferrous fumarate, folic acid, nicotinamide, pyridoxine hydrochloride, retinol acetate, riboflavin, thiamine mononitrate, tocopheryl acetate, zinc oxide (PRENATAL VITAMINS [ASCORBIC ACID;BETACAROTENE;CALCIUM SULFATE;COLECALCIFEROL;CYANOCOBALAMIN;FERROUS FUMARATE;FOLIC ACID;NICOTINAMIDE;PYRIDOXINE HYDROCHLORIDE;RETINOL ACETATE;RIBOFLAVIN;THIAMINE MONONITRATE;TOCOPHERYL ACETATE;ZINC OXIDE]), naproxen sodium (NAPROSYN). It was unknown if the patient is pregnant at the of vaccination. The patient was not diagnosed with COVID prior vaccination. The patient did not receive other vaccines within four weeks prior to COVID vaccination. The vaccine was administered in the hospital. On 07Jan2021, at 13:00, the patient experienced headache (minor) day of. The patient experienced arm soreness (minor) day after (08Jan2021). The patient received naproxen as treatment for the events. Outcome of the events was recovered.

Other Meds: PRENATAL VITAMINS [ASCORBIC ACID;BETACAROTENE;CALCIUM SULFATE;COLECALCIFEROL;CYANOCOBALAMIN;FERROUS ; NAPROSYN [NAPROXEN SODIUM]

Current Illness:

ID: 0945983
Sex: F
Age:
State:

Vax Date: 01/07/2021
Onset Date: 01/09/2021
Rec V Date: 01/15/2021
Hospital:

Lab Data: Test Date: 20210109; Test Name: Fever; Result Unstructured Data: Test Result:Fever

Allergies:

Symptoms: Fever; nausea; body aches; sore throat; cough; headache; This is a spontaneous report from a contactable nurse (reported for herself). A 23-year-old female patient (not pregnant at the time of vaccination) received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL 142), intramuscular on 07Jan2021 at single dose at right arm for COVID-19 immunization. Medical history included known allergies: Penicillin, diagnosed with COVID-19 prior to vaccination. The patient's concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Facility type Vaccine was Doctor's office/urgent care. The patient experienced Fever, nausea, body aches, sore throat, cough, headache on 09Jan2021. No treatment received for the adverse events. The events were non-serious per the reporter. Since the vaccination, the patient hadn't been tested for COVID-19. The outcome of the events was not recovered.

Other Meds:

Current Illness:

ID: 0945984
Sex: F
Age:
State: TX

Vax Date: 12/21/2020
Onset Date: 12/21/2020
Rec V Date: 01/15/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Slight allergic reaction; itchiness immediately after the injection in the injection area; itchiness spread to parts of patients body like the back of her throat and tongue; itchiness spread to parts of the patients body like the back of their throat and tongue; itching to the area of the leg, the face, the head; This is a spontaneous report from a contactable consumer (patient). The 51-year-old patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiry date were unknown) intramuscular (upper left arm), on 21Dec2020, at a single dose, for COVID-19 immunization/ prophylaxis. Relevant medical history included root canal. The patient has no concomitant medications. The patient previously took thimerosal (preservative) and experienced allergy. Patient knows the vaccine is preservative free. The patient received the first dose on 21Dec2020. She had a slight allergic reaction where she experienced itchiness immediately after the injection in the injection area (itching in the arm) and the itchiness spread to parts of her body like the back of her throat, tongue, area of the leg, the face, the head. She took three Benadryl as treatment for these events. The patient recovered completely that same evening (on 21Dec2020) before she went to bed around 10 or 11 that night after her third Benadryl. She was due to go back to get her second dose between 11Jan2021 and 13Jan2021, next week. She is concerned about getting the second dose since she had somewhat of a reaction with the first dose. She had to have a root canal and she was taking an antibiotic which she clarifies as a Z-pack, azithromycin. States her last antibiotic pill is due to be taken on Monday, 11Jan2021. She was asking if she can get the second dose. She is also concerned about how she may react to the 2nd dose of the vaccine while taking Azithromycin. They were informed at work that the 2nd dose of the vaccine should be administered between days 21 and 23 after the first one. Information about lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0945985
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 01/15/2021
Hospital:

Lab Data:

Allergies:

Symptoms: blurry vision; double vision; This is a spontaneous report from a non-contactable consumer. This consumer reported same events for two patients. This is first of two reports. A 7 decades old female patient received bnt162b2, via an unspecified route of administration on an unspecified date at single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced blurry vision, double vision on an unspecified date. The reporter told that her elderly aunt and uncle (ages 60+ and 80+) received the Pfizer vaccine and experienced blurry vision and double vision. The outcome of events was resolving. Information about Lot/Batch number is requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021015734 same reporter/drug/AE with different patient

Other Meds:

Current Illness:

ID: 0945986
Sex: F
Age:
State: OK

Vax Date: 12/17/2020
Onset Date:
Rec V Date: 01/15/2021
Hospital:

Lab Data:

Allergies:

Symptoms: sore/pain injection site; This is a spontaneous report from a contactable nurse (patient herself). A 56-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EH9899; expiry date: unknown) intramuscular (left arm) on 17Dec2020 at 15:15, at a single dose, for COVID-19 immunization. Relevant medical history included hypertension (HTN), hypothyroid, and early pulmonary HTN. Concomitant medications were not reported. The patient previously received bactroban ointment and experienced allergies. Patient is a registered nurse working in a small, rural hospital. The patient is not pregnant at the time of vaccination. The patient was not diagnosed with COVID prior vaccination. The patient did not receive other vaccines within four weeks prior to COVID vaccination. The vaccine was administered in the hospital. On an unspecified date, the patient experienced sore/pain injection site. Outcome of the event was unknown. The patient has not been tested for COVID-19 since vaccination.

Other Meds:

Current Illness:

ID: 0945987
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 01/15/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Blurry vision; double vision; This is a spontaneous report from a non-contactable consumer. This consumer reported similar events for 2 patients. This is 2nd of 2 reports. A 9-decade-old (80+) male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The reporter reported her elderly uncle experienced blurry vision and double vision on an unspecified date with outcome of recovering. Information about lot/batch number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021015730 same reporter/drug/AE with different patient.

Other Meds:

Current Illness:

ID: 0945988
Sex: F
Age:
State: NC

Vax Date: 01/07/2021
Onset Date: 01/08/2021
Rec V Date: 01/15/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Left arm went total numb for over 72 hours; Red and swollen all the way up to the shoulder; Red and swollen all the way up to the shoulder; Red and swollen all the way up to the shoulder; Tighten in chest; Weakness; dizziness; Slept for over 24 hours; Nausea; vomiting; This is a spontaneous report from a contactable other Health Professional (HCP) (patient). A 46-year-old non-pregnant female patient received her second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: Ek9231), via an unspecified route of administration on 07Jan2021 14:30 at single dose in her left arm for covid-19 immunization. Medical history included dermatitis contact and asthma. The patient had allergies to medications, food, or other products. The patient did not receive any other medications within 2 weeks of vaccination. The patient previously received her first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: Ek5730) at single dose in her left arm on 17Dec2020 14:30 for covid-19 immunization. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient had not been tested for COVID-19. The patient experienced feft arm went total numb for over 72 hours, red and swollen all the way up to the shoulder, tighten in chest, weakness and dizziness, slept for over 24 hours, nausea and vomiting on 08Jan2021 04:30. The events result in doctor or other healthcare professional office/clinic visit. The patient received prednisone 100 mg to treat these events. The outcome of the events was recovered in Jan2021.

Other Meds:

Current Illness:

ID: 0945989
Sex: F
Age:
State: CA

Vax Date: 01/04/2021
Onset Date: 01/04/2021
Rec V Date: 01/15/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Woke up with moderate fatigue, nausea, more severe arm pain than day before; Woke up with moderate fatigue, nausea, more severe arm pain than day before; Felt sweaty/chills, neck lymph glands tender; Felt sweaty/chills, neck lymph glands tender; neck lymph glands tender; Moderate arm pain that night; This is a spontaneous report from a contactable Nurse (patient). A 52-year-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/lot number: EL1284), intramuscularly on 04Jan2021 16:30 at single dose for COVID-19 immunization. Anatomical Located at Arm Right. The patient medical history was not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medication which the patient received within 2 weeks of vaccination included colecalciferol (VITAMIN D), tocopherol (VITAMIN E), magnesium, ibuprofen, paracetamol (TYLENOL). The patient previously took amoxicillin and experienced allergy. Prior to vaccination, the patient did not diagnose with COVID-19. Since the vaccination, the patient was not tested for COVID-19. The patient experienced Moderate arm pain that night on 04Jan2021 19:00 and woke up with moderate fatigue, nausea, more severe arm pain than day before on 05Jan2021. At 23 hours post injection on 05Jan2021, the patient also felt sweaty/chills, neck lymph glands tender. All symptoms gone at 48 hrs post injection. The patient did not receive any treatment for the reported events. The outcome of the events was recovered in Jan2021. This case reported as non-serious.

Other Meds: VITAMIN D; VITAMIN E [TOCOPHEROL]; ; ; TYLENOL

Current Illness:

ID: 0945990
Sex: F
Age:
State: TX

Vax Date: 01/08/2021
Onset Date: 01/08/2021
Rec V Date: 01/15/2021
Hospital:

Lab Data:

Allergies:

Symptoms: When the patient got sick she got a rash that didn't itch all over her body; Chills; aching; fever; This is a spontaneous report from a contactable other health professional (patient). A 30-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 08Jan2021 06:45 AM at left arm, at single dose for covid-19 immunization. Medical history was none. Known allergies was no. There were no concomitant medications. The patient was not pregnant at the time of vaccination. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, unknown lot number and expiration date), via an unspecified route of administration on 18Dec2020 06:30 AM at left arm, at single dose for covid-19 immunization. The patient experienced chills, aching and fever 10 hours later at 08Jan2021 18:30. When the patient got sick she got a rash that didn't itch all over her body and it happened 24 hours after the vaccine, on 09Jan2021. No treatment was received for all events. The outcome of the events was recovering. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. No seriousness criteria: no Results in death, no Life threatening, no Caused/prolonged hospitalization, no Disabling/Incapacitating, no Congenital anomaly/birth defect. Information on lot number/batch number was requested.

Other Meds:

Current Illness:

ID: 0945991
Sex: F
Age:
State: MO

Vax Date: 01/07/2021
Onset Date: 01/08/2021
Rec V Date: 01/15/2021
Hospital:

Lab Data: Test Date: 20210108; Test Name: Fever; Result Unstructured Data: Test Result:100.4; Comments: 12:15 am

Allergies:

Symptoms: Fever 100.4, full body aches, chills, injection site soreness, weakness, dizziness, nausea, low back pain; Fever 100.4, full body aches, chills, injection site soreness, weakness, dizziness, nausea, low back pain; Fever 100.4, full body aches, chills, injection site soreness, weakness, dizziness, nausea, low back pain; Fever 100.4, full body aches, chills, injection site soreness, weakness, dizziness, nausea, low back pain; Fever 100.4, full body aches, chills, injection site soreness, weakness, dizziness, nausea, low back pain; Fever 100.4, full body aches, chills, injection site soreness, weakness, dizziness, nausea, low back pain; Fever 100.4, full body aches, chills, injection site soreness, weakness, dizziness, nausea, low back pain; Fever 100.4, full body aches, chills, injection site soreness, weakness, dizziness, nausea, low back pain; This is a spontaneous report from a contactable other-HCP (patient). A 28-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number EJ1686), via an unspecified route of administration on 07Jan2021 13:45 at single dose for covid-19 immunization. Vaccine location was left arm and it was the second dose. Patient is not pregnant. The facility type vaccine was hospital. Patient took the first dose of BNT162B2 on 17Dec2021 13:45 (lot number EK5730) at arm left for covid-19 immunization. The patient medical history was not reported. Concomitant medication included famotidine and birth control. The known allergies included Cefzil. Patient was not diagnosed with COVID-19 prior to vaccination nor tested for COVID-19 since the vaccination. The patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced Fever 100.4, full body aches, chills, injection site soreness, weakness, dizziness, nausea, low back pain on 08Jan2021 00:15 with outcome of recovering. Patient didn't receive treatment for the adverse events. The events were reported as non-serious.

Other Meds:

Current Illness:

ID: 0945992
Sex: F
Age:
State:

Vax Date: 12/19/2020
Onset Date: 01/07/2021
Rec V Date: 01/15/2021
Hospital:

Lab Data: Test Name: COVID test; Test Result: Negative

Allergies:

Symptoms: Body, muscle and joint pain; Body, muscle and joint pain; Body, muscle and joint pain; Chills; Tired; This is a spontaneous report from a non-contactable healthcare professional. A 48-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 19Dec2020 (13:00) (Lot number: EK5730; Expiration date was not reported) and the second dose on 07Jan2021 (07:00) (Lot number: EL0140; Expiration date was not reported), both intramuscularly on the left arm at a single dose for COVID-19 immunization at the hospital. Medical history included sulfa allergy. Concomitant medications included colecalciferol (VITA D) and magnesium sulfate (MG). On 07Jan2021 (19:30), the patient had body, muscle and joint pain; chills; and tired. The patient did not receive any treatment for the events. The patient's COVID test was negative on an unspecified date. The patient was not diagnosed with COVID-19 prior to vaccination, and had not been tested since the vaccination. The outcome of the events, 'body, muscle and joint pain', 'chills' and 'tired', was recovering. No follow-up attempts are possible; Information about lot/batch number cannot be obtained.

Other Meds: VITA D [COLECALCIFEROL]; MG [MAGNESIUM SULFATE]

Current Illness:

ID: 0945993
Sex: F
Age:
State: IL

Vax Date: 01/07/2021
Onset Date: 01/08/2021
Rec V Date: 01/15/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Swollen and painful lymph nodes under arms; Swollen and painful lymph nodes under arms; This is a spontaneous report from a contactable nurse (patient herself). A 40-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EL3248; expiry date: unknown) via intramuscular route in the left arm, on 07Jan2021 at 14:00, at a single dose, for COVID-19 immunization. Relevant medical history included anxiety, depression, hypothyroid, and hypertension. The patient has no known allergies. Concomitant medications included levothyroxine, escitalopram, paracetamol (TYLENOL), ibuprofen, and marijuana. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EJ1685) intramuscular route in the left arm, on 18Dec2020 at 13:00, for COVID-19 immunization. The patient is not pregnant at the time of vaccination. The patient was not diagnosed with COVID prior vaccination. The patient did not receive other vaccines within four weeks prior to COVID vaccination. The vaccine was administered in the hospital. On 08Jan2021, at 21:00, the patient experienced swollen and painful lymph nodes under arms. The patient did not receive treatment for the events. Outcome of the events was not recovered. The patient has not been tested for COVID-19 since vaccination.

Other Meds: ; ; TYLENOL; ; MARIJUANA

Current Illness:

ID: 0945994
Sex: M
Age:
State: NY

Vax Date: 01/07/2021
Onset Date: 01/08/2021
Rec V Date: 01/15/2021
Hospital:

Lab Data:

Allergies:

Symptoms: muscle aches; Headache; This is a spontaneous report from a contactable healthcare professional, the patient. A 37-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Lot Ek9231) solution for injection in the left arm on 07Jan2021 at 18:15 (at the age of 37-years-old) as a single dose for COVID-19 vaccination. Medical history was not reported. Concomitant medication included unspecified vitamins. The patient did not receive any other vaccine within 4 weeks prior to the vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 08Jan2021 at 20:00, the patient experienced muscle aches and headache. No treatment was provided for the events muscle aches and headache. The outcome of the events muscle aches and headache was not recovered. Since the vaccination, the patient has not been tested for COVID-19.

Other Meds:

Current Illness:

ID: 0945995
Sex: F
Age:
State: OH

Vax Date: 01/07/2021
Onset Date: 01/07/2021
Rec V Date: 01/15/2021
Hospital:

Lab Data: Test Date: 20210107; Test Name: Fever; Result Unstructured Data: Test Result:up to 101.4; Comments: fever up to 101.4

Allergies:

Symptoms: Chills, shaking, body aches, fever up to 101.4, vomiting Began about 12 hours after administration of shot. Lasted approximately 10 hours; Chills, shaking, body aches, fever up to 101.4, vomiting Began about 12 hours after administration of shot. Lasted approximately 10 hours; Chills, shaking, body aches, fever up to 101.4, vomiting Began about 12 hours after administration of shot. Lasted approximately 10 hours; Chills, shaking, body aches, fever up to 101.4, vomiting Began about 12 hours after administration of shot. Lasted approximately 10 hours; Chills, shaking, body aches, fever up to 101.4, vomiting Began about 12 hours after administration of shot. Lasted approximately 10 hours; This is a spontaneous report from a contactable other health care professional (patient). A 31-year-old female patient started to receive BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EK9231), via an unspecified route of administration (left arm) second dose on 07Jan2021 09:30 at single dose for covid-19 immunisation. The patient's medical history included known allergies: Sulfa drugs and known allergies: latex sensitivity. The patient's concomitant medication included spironolactone, bifidobacterium lactis (PROBIOTIC [BIFIDOBACTERIUM LACTIS]), and multi vitamin. The patient previously took BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), for covid-19 immunisation first dose on 17Dec2020, Vaccine location Left arm, lot number EH9899. On 07Jan2021 10:00 PM, the patient experienced Chills, shaking, body aches, fever up to 101.4, vomiting Began about 12 hours after administration of shot. Lasted approximately 10 hours. The patient did not received treatment for the events. The outcome of the events was recovered in Jan2021. Facility where the most recent COVID-19 vaccine was administered in Hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not tested positive for covid post vaccination.

Other Meds: ; PROBIOTIC [BIFIDOBACTERIUM LACTIS]

Current Illness:

ID: 0945996
Sex: F
Age:
State: NJ

Vax Date: 01/08/2021
Onset Date: 01/08/2021
Rec V Date: 01/15/2021
Hospital:

Lab Data:

Allergies:

Symptoms: malaise; headache; low grade fever; dizziness; overall body aches; This is a spontaneous report from a contactable other healthcare professional (patient). A 63-year-old female patient (not pregnant) received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot/batch number and expiration date not provided as unable to locate or read the details), intramuscularly on 08Jan2021 at 10:30 AM on Left arm at single dose for COVID-19 immunization in hospital. The patient's medical history and concomitant medications were not reported. The patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot/batch number and expiration date not provided) intramuscularly on 18Dec2020 at 10:15 AM on Left arm at single dose for COVID-19 immunization at age of 63-year-old. Prior to vaccination, patient was not diagnosed with COVID-19. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced malaise, headache, low grade fever, dizziness, overall body aches on 08Jan2021 at 19:00. Since the vaccination, patient had not been tested for COVID-19. No treatment was received for the events. The outcome of the events was recovering. The report was reported as non-serious, with seriousness criteria-Results in death: No; Life threatening: No; Caused/prolonged hospitalization: No; Disabling/Incapacitating: No; Congenital anomaly/birth defect: No. Information on the Lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0945997
Sex: F
Age:
State: TX

Vax Date: 01/05/2021
Onset Date: 01/05/2021
Rec V Date: 01/15/2021
Hospital:

Lab Data: Test Date: 20210107; Test Name: Nasal Swab; Result Unstructured Data: Test Result:Negative

Allergies:

Symptoms: Palm-sized discoloration around injection site; arm was very sore; This is a spontaneous report from a non-contactable consumer (patient). A 43-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 05Jan2021 12:00 in left arm at single dose for COVID-19 immunization. Medical history included hay fever, asthma, various allergies and high blood pressure from an unknown date and unknown if ongoing. Concomitant medication included progesterone, metformin, atorvastatin and metoprolol. On 05Jan202115:00, the patient experienced palm-sized discoloration around injection site and arm was very sore for two days. No treatment was given to the patient for the events. The patient recovered from the events on unspecified date. The patient underwent laboratory test which includes nasal swab: negative on 07Jan2021. The facility where the most recent COVID-19 vaccine was administered was in the hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The events were considered non serious as it did not result in death, was not life threatening, did not cause/prolonged hospitalization, was not disabling/Incapacitating and had no congenital anomaly/birth defect. No follow-up attempts are possible; information about lot/batch cannot be obtained.

Other Meds: ; ; ;

Current Illness:

ID: 0945998
Sex: M
Age:
State: WI

Vax Date: 01/07/2021
Onset Date: 01/08/2021
Rec V Date: 01/15/2021
Hospital:

Lab Data: Test Name: fever; Result Unstructured Data: Test Result:100.0; Comments: Fever of 100.0 orally

Allergies:

Symptoms: After my second vaccine, I have developed a dry cough/I have had the cough for 24 hours so far; at the same time I experienced the more typical symptoms (mild fatigue, malaise, muscle aches, fever of 100.0 orally); at the same time I experienced the more typical symptoms (mild fatigue, malaise, muscle aches, fever of 100.0 orally); at the same time I experienced the more typical symptoms (mild fatigue, malaise, muscle aches, fever of 100.0 orally); at the same time I experienced the more typical symptoms (mild fatigue, malaise, muscle aches, fever of 100.0 orally); This is a spontaneous report from a contactable physician (patient). A 59-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via Intramuscular at single dose in the right arm, first dose (lot: EK5730) on 17Dec2020 11:30 am, second dose (lot EL0142) on 07Jan2021 18:00, both for COVID-19 immunisation. Medical history was none. Concomitant medications were not reported. After his second vaccine, on 08Jan2021, he has developed a dry cough at the same time he experienced the more typical symptoms (mild fatigue, malaise, muscle aches, fever of 100.0 orally). He has no known exposure to Covid 19 in the last few weeks. He has had the cough for 24 hours so far. The patient did not receive any treatment. Outcome of events was recovering.

Other Meds:

Current Illness:

ID: 0945999
Sex: F
Age:
State: PA

Vax Date: 12/17/2020
Onset Date: 12/18/2020
Rec V Date: 01/15/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Funky lightheadedness; Normal tinnitus got louder and oscillating up and down; Sinus headache; Vertigo; This is a spontaneous report from a contactable pharmacist. A 50-year-old female (not pregnant at the time of vaccination) patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number EK5730), intramuscular at arm right on 17Dec2020 13:30 at single dose for COVID-19 immunization at a Workplace clinic. The patient's medical history was reported as none. No known drug allergies. Concomitant medication (received within 2 weeks of vaccination) included ergocalciferol (VIT D). The patient was not diagnosed with COVID-19 prior to vaccination. It was reported that while getting first dose, patient experienced instant "funky lightheadedness, vertigo. Normal tinnitus got louder and oscillating up and down. Next day after first dose (18Dec2020), patient had sinus headache and vertigo, took meclizine and went back to bed. Felt fine when she woke up. The outcome of the events sinus headache and vertigo was recovered on an unspecified date, for the rest of events was unknown. The reporter consider the evens as non-serious.

Other Meds: VIT D

Current Illness:

ID: 0946000
Sex: F
Age:
State: NC

Vax Date: 01/07/2021
Onset Date: 01/08/2021
Rec V Date: 01/15/2021
Hospital:

Lab Data:

Allergies:

Symptoms: flu-like symptoms; dizziness; heavy feet; This is a spontaneous report from a contactable pharmacist reporting for herself. A 55-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: ek9231), via an unspecified route of administration on 07Jan2021 13:45 in left arm at single dose for COVID-19 immunization. Medical history included allergies to cherries and hazelnuts amd Hashimoto's thyroiditis from an unknown date and unknown if ongoing; h/o possible GBS (Guillain-Barre syndrome) from an unknown date and unknown if ongoing post influenza vaccine in 2016. Concomitant medication included fish oil, minerals nos, quercetin, thioctic acid, vitamins (EMERGEN-C) and multivitamins. On 08Jan2021, the patient experienced flu-like symptoms and bouts of dizziness, and a feeling of "heavy feet" 24 hours post administration of BNT162B2. No treatment was given to the patient for the events. The outcome of the events was unknown. The facility where the most recent COVID-19 vaccine was administered was in the hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The events were considered non serious as it did not result in death, was not life threatening, did not cause/prolonged hospitalization, was not disabling/Incapacitating and had no congenital anomaly/birth defect.

Other Meds: ; EMERGEN-C

Current Illness:

ID: 0946001
Sex: F
Age:
State: CO

Vax Date: 12/20/2020
Onset Date: 12/20/2020
Rec V Date: 01/15/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Migraine headache; This is a spontaneous report from a contactable nurse reporting for herself. A 38-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EJ1685), intramuscular from 20Dec2020 11:00 in left arm to 20Dec2020 11:00 at single dose for COVID-19 immunization. Medical history was reported as none. Concomitant medication included cetirizine hydrochloride (ZYRTEC). On 20Dec2020 17:00, the patient experienced migraine headache approximately 6hrs after injection. The patient recovered on unspecified date. No treatment was given to the patient for the event. The facility where the most recent COVID-19 vaccine was administered was in the Public Health Clinic/Veterans Administration facility. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The event was considered non serious as it did not result in death, was not life threatening, did not cause/prolonged hospitalization, was not disabling/Incapacitating and had no congenital anomaly/birth defect.

Other Meds: ZYRTEC [CETIRIZINE HYDROCHLORIDE]

Current Illness:

ID: 0946002
Sex: F
Age:
State:

Vax Date: 01/08/2021
Onset Date:
Rec V Date: 01/15/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Swollen painful lymph nodes left armpit; Swollen painful lymph nodes left armpit; This is a spontaneous report from a non-contactable nurse reporting for herself. A 41-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 08Jan2021 08:00 in left arm at single dose for COVID-19 immunization. Medical history included sulfa allergy from an unknown date and unknown if ongoing. Concomitant medication included buspirone hydrochloride (BUSPAR), lamotrigine (SUBVENITE) and quetiapine fumarate (SEROQUEL). The patient previously took amoxicillin and experienced allergies and received first dose of BNT162B2. The patient experienced swollen painful lymph nodes left armpit on an unspecified date. The outcome of the events was unknown. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The events was considered non serious as it did not result in death, was not life threatening, did not cause/prolonged hospitalization, was not disabling/Incapacitating and had no congenital anomaly/birth defect. No follow-up attempts are possible. No further information is expected.

Other Meds: BUSPAR; SUBVENITE; SEROQUEL

Current Illness:

ID: 0946003
Sex: F
Age:
State:

Vax Date: 01/05/2021
Onset Date: 01/05/2021
Rec V Date: 01/15/2021
Hospital:

Lab Data:

Allergies:

Symptoms: trouble lifting things like my tea kettle; lot of pain in right elbow; bad neck and shoulder pain; bad neck and shoulder pain; sore right arm similar to after a tetanus shot; This is a spontaneous report from a non-contactable nurse (patient). A 61-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), Lot number: EL1284, intramuscular on right arm from 05Jan2021 09:45 to 05Jan2021 09:45 as single dose (first dose) for COVID-19 immunisation. Medical history included none. The patient's concomitant medications were not reported. On 05Jan2021 at 03:00pm, the patient experienced sore right arm similar to after a tetanus shot. On 06Jan2021, the pain in upper arm gone but by afternoon but the patient got bad neck and shoulder pain on right side that she treated with heat and Advil. On 07Jan201, neck pain still present and by late afternoon, the patient got a lot of pain in right elbow. On 08Jan2021, the patient still have the neck to shoulder pain in addition to the right elbow pain. It feels like she sprained her elbow and was having trouble lifting things like my tea kettle. The outcome of the event sore right arm/pain in upper arm was recovered on 06Jan2021; having trouble lifting things like my tea kettle was unknown; while the other events were not recovered. Treatment has been given for the event bad neck and shoulder pain. Since the vaccination, the patient has not been tested for COVID-19. No follow up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 0946004
Sex: F
Age:
State: MN

Vax Date: 01/06/2021
Onset Date: 01/09/2021
Rec V Date: 01/15/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Rash around entire neck; Swollen lymph nodes; This is a spontaneous report from a contactable nurse (patient). A 22-year-old female patient received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK9231) solution for injection, intramuscular on left arm on 06Jan2021 12:00 at a single dose for Covid-19 immunization. Medical history included scoliosis, sport-induced asthma, and seasonal allergies. Concomitant medications included cetirizine hydrochloride (ZYRTEC [CETIRIZINE HYDROCHLORIDE]), ibuprofen (IBUPROFEN), and meclozine hydrochloride (BONINE). The patient experienced rash around entire neck and swollen lymph nodes, both on 09Jan2021 06:00. No treatment received. The events were reported as non-serious. Patient was not diagnosed with Covid-19 prior to vaccination. Patient has not tested for Covid-19 since the vaccination. Outcome of the event was not recovered. No follow-up activities are needed. No further information is expected.

Other Meds: ZYRTEC [CETIRIZINE HYDROCHLORIDE]; ; BONINE

Current Illness:

ID: 0946005
Sex: F
Age:
State: WI

Vax Date: 01/08/2021
Onset Date: 01/09/2021
Rec V Date: 01/15/2021
Hospital:

Lab Data:

Allergies:

Symptoms: I woke about 3 am and had paresthesia of my fingers on my right hand. Thumb, index, middle and ring fingers. I Thought that I had slept in my hand wrong.; The discomfort at injection site woke me again last night and had the same feeling. It has remained after waking this morning; This is a spontaneous report from a contactable physician (patient). A 50-year-old female patient received her second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK 7530) solution for injection, via an unspecified route of administration on right arm on 08Jan2021 13:15 at a single dose for COVID-19 immunization. Medical history was reported as none. The patient has no allergies to food, medications, or other products. The patient was not pregnant. Patient had the first dose of BNT162B2 on 18Dec2020 (lot number: EK 7530). Concomitant medications included multivitamins [vitamins nos] (MULTIVITAMINS [VITAMINS NOS]), ascorbic acid, biotin, folic acid, iodine, pantothenic acid, pyridoxine hydrochloride, retinol, vitamin b12 nos, vitamin d nos, vitamin e nos, zinc (CENTRUM MULTIGUMMIES), and melatonin at 1.5 mg, daily. The patient reported that on 09Jan2021, she woke about 3 am and had paresthesia of her fingers on her right hand, thumb, index, middle and ring fingers. She thought that she had slept in her hand wrong. The discomfort at injection site woke her again last night (09Jan2021) and had the same feeling. It has remained after waking this morning. No treatment was given. The patient was not diagnosed with Covid-19 prior to vaccination and has not been tested for Covid-19 since vaccination. Outcome of the events was not recovered. No follow-up activities are needed. No further information is expected.

Other Meds: MULTIVITAMINS [VITAMINS NOS]; CENTRUM MULTIGUMMIES;

Current Illness:

ID: 0946006
Sex: F
Age:
State:

Vax Date: 12/15/2020
Onset Date: 12/15/2020
Rec V Date: 01/15/2021
Hospital:

Lab Data:

Allergies:

Symptoms: hives after first shot; This is a spontaneous report from a non-contactable healthcare professional (patient). A 27-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) solution for injection, via an unspecified route of administration, the first dose on 15Dec2020 (lot number: EH9899) at a single dose, then the second dose on 08Jan2021 (lot number: EK9231) at a single dose, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient was not pregnant. The patient experienced hives after first shot on 15Dec2020. No treatment received. Outcome of the event was recovered. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 0946007
Sex: F
Age:
State: NY

Vax Date: 01/06/2021
Onset Date: 01/06/2021
Rec V Date: 01/15/2021
Hospital:

Lab Data: Test Date: 20201227; Test Name: Nasal Swab/ PCR; Test Result: Negative

Allergies:

Symptoms: Sore throat; congested; 2nd dose - lethargic for 24 hours.; intense muscle and joint pain for about 48 hours from proximal kneels to neck (hurt to move, shoulder flexibility pain free range 0-30 degrees, couldn't lay on right arm).; intense muscle and joint pain for about 48 hours from proximal kneels to neck (hurt to move, shoulder flexibility pain free range 0-30 degrees, couldn't lay on right arm).; first dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 18Dec2020/ second dose of BNT162B2 on 06Jan2021; first dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 18Dec2020/ second dose of BNT162B2 on 06Jan2021; This is a spontaneous report from a contactable consumer (patient). A 35-year-old female patient received her second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: Ek9231, expiration date 30Apr2021), via an unspecified route of administration on right arm at 08:30 AM on 06Jan2021 at single dose for COVID-19 immunization. Medical history included hypothyroid. Concomitant medication included levothyroxine, vitamin c [ascorbic acid] (VITAMIN C [ASCORBIC ACID]), colecalciferol (VITAMIN D) and multivitamin. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient received her first dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 18Dec2020 at single dose for COVID-19 immunization and experienced minimal pain right deltoid area. For the second dose, the patient experienced lethargic for 24 hours, intense muscle and joint pain for about 48 hours from proximal kneels to neck (hurt to move, shoulder flexibility pain free range 0-30 degrees, couldn't lay on right arm). Took Tylenol to decrease muscle and joint pain, which helped. Day 4 post vaccine on 10Jan2021, slight sore throat, congested, but muscle and joint pain generally resolved. It was only day 4. The outcome of events muscle pain and joint pain was recovered on 10Jan2021, the outcome of reset events was not recovered. Prior to vaccination, the patient was not diagnosed with COVID-19; Since the vaccination, the had not patient been tested for COVID-19.

Other Meds: ; VITAMIN C [ASCORBIC ACID]; VITAMIN D [COLECALCIFEROL]

Current Illness:

ID: 0946008
Sex: F
Age:
State: MA

Vax Date: 01/06/2021
Onset Date: 01/07/2021
Rec V Date: 01/15/2021
Hospital:

Lab Data:

Allergies:

Symptoms: fever; chills/Shivering; pelvic pain; nausea; headache; This is a spontaneous report from a contactable consumer. A 34-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE lot/batch number: not provided), via an unspecified route of administration on the left arm on 06Jan2021 15:15 at SINGLE DOSE for COVID-19 immunization at the hospital. Medical history was reported as none. Concomitant medications were not reported. The patient previously received the first dose of PFIZER-BIONTECH COVID-19 VACCINE (lot/batch number: not provided) via unknown route of administration on the left arm on 20Dec2020 16:15 at a single dose for COVID-19 immunization. On 07Jan2021 04:00, the patient had fever, chills/shivering, pelvic pain, headache, and nausea symptoms resolved next day (08Jan2021). Prior to vaccination the patient was not diagnosed with COVID-19 and since the vaccination, has not been tested for COVID-19. The patient did not receive any treatment for the events. Information about lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0946009
Sex: F
Age:
State: OH

Vax Date: 12/28/2020
Onset Date: 12/31/2020
Rec V Date: 01/15/2021
Hospital:

Lab Data: Test Date: 20210106; Test Name: Nasal Swab; Result Unstructured Data: Test Result:Negative

Allergies:

Symptoms: Change is related to sense of smell. Sweet aromas are not the same, the perception of sweeter aromas is altered.; This is a spontaneous report from a contactable nurse (patient). A 47-year-old female patient received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL0140) solution for injection, via an unspecified route of administration on left arm on 28Dec2020 12:30 at a single dose for COVID-19 immunization. The patient medical history included allergy to echinacea. The patient was not pregnant. Concomitant medications included vitamin b complex and glucosamine. The patient reported that a change was related to sense of smell. Sweet aromas were not the same, the perception of sweeter aromas was altered on 31Dec2020. No treatment was received. The patient underwent nasal swab and tested negative on 06Jan2021. Outcome of the event was not recovered. No follow-up activities are needed. No further information is expected.

Other Meds: VIT B COMPLEX;

Current Illness:

ID: 0946010
Sex: F
Age:
State: PA

Vax Date: 01/06/2021
Onset Date: 01/07/2021
Rec V Date: 01/15/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Myalgia; Chills; Nausea; Joint pain; Headache; Fatigue; This is a spontaneous report from a non-contactable pharmacist (patient herself). A 29-year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL0140, expiry date not reported), via an unspecified route of administration in the right arm on 06Jan2021 18:15 at a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient was not pregnant at the time of vaccination. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, the patient has not been tested for COVID-19. The patient had no allergies to medications, food, or other products. The patient previously took first dose of bnt162b2 (lot number: EL0140, expiry date not reported) in the right arm on 18Dec2020 at single dose for COVID-19 immunisation. On 07Jan2021 at 02:00, the patient experienced myalgia, chills, nausea, joint pain, headache and fatigue. No therapeutic measure was taken as a result of the events. Clinical outcome of the events was recovered on 08Jan2021 at 02:00. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 0946011
Sex: F
Age:
State: MA

Vax Date: 01/07/2021
Onset Date: 01/08/2021
Rec V Date: 01/15/2021
Hospital:

Lab Data: Test Date: 20201108; Test Name: Nasal Swab; Test Result: Negative ; Test Date: 20201205; Test Name: Nasal Swab; Test Result: Negative

Allergies:

Symptoms: fever; chills; muscle aches; This is a spontaneous report form a contactable other healthcare professional (Other HCP) reporting for herself. A 22-year-old female patient received the second dose of bnt162b2 (BNT162B2, lot number: EK9231, expiry date: not reported) via an unspecified route of administration, on 07Jan2021 on Arm Left at a single dose for COVID-19 immunization. COVID-19 vaccine was administered at a hospital. Medical history was not reported. The patient has no known allergies to medications, food, or other products. The patient was not pregnant at the time of vaccination. She did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient had undergone Nasal Swab tests on 08Nov2020 and 05Dec2020, both with negative results. Concomitant medications were not reported. The patient previously received the first dose of bnt162b2 (BNT162B2, lot number: EK5730, expiry date: not reported) via an unspecified route of administration, on 17Dec2020 03:30 PM on Arm Right at a single dose for COVID-19 immunization (at the age of 22-year-old). On 08Jan2021 02:45 AM, the patient had a fever, chills and muscle aches in the middle of the night into the morning of the following day. Treatment was not received for the adverse events. Outcome of the events was recovering.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 134,999

Page last modified: 14 December 2021 10:42pm